Victor N. Uebele

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

6

H-Index

1

About

Victor N. Uebele is a distinguished pharmaceutical researcher whose work centers on assay development, high-throughput screening, and lead optimization in drug discovery. His major contributions include pioneering automated platforms that streamline the complex process of cross-titration experiments—critical for determining compound potency and efficacy during hit triage and lead optimization. His 2016 paper, "Development of a Platform to Enable Fully Automated Cross-Titration Experiments," which has garnered 6 citations, introduced a transformative approach to conducting agonist shift studies and multi-concentration testing with unprecedented efficiency. This work has helped accelerate the identification of promising drug candidates by reducing manual labor and increasing reproducibility in pharmacological profiling. Uebele’s innovations are particularly valuable in the pharmaceutical industry, where rapid and accurate characterization of compound activity is essential. His contributions have enabled researchers to more effectively navigate the challenging transition from initial hits to optimized leads, ultimately supporting the development of new therapeutics. Through his focus on automation and methodological rigor, Uebele has made a lasting impact on the practice of modern drug discovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Development of a Platform to Enable Fully Automated Cross-Titration Experiments
6 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago